- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (287)
- Timeline of Article Publication (0)
- Authors Evaluation (1)
- Article Quality Tracking (0)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6524)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 28, 2023 (publication date) through Jun 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Saengboonmee C, Sorin S, Sangkhamanon S, Chomphoo S, Indramanee S, Seubwai W, Thithuan K, Chiu CF, Okada S, Gingras MC, Wongkham S. γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus. World J Gastroenterol 2023; 29(28): 4416-4432 [PMID: 37576707 DOI: 10.3748/wjg.v29.i28.4416] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i28/4416.htm |
| Number | Citing Articles |
| 1 |
Ronnakrit Trakoonsenathong, Ching-Feng Chiu, Charupong Saengboonmee. Glucagon-like peptide 1 receptor agonist: A potential game changer for cholangiocarcinoma. World Journal of Gastroenterology 2024; 30(34): 3862-3867 doi: 10.3748/wjg.v30.i34.3862
|
| 2 |
A. F. Al-Azzawie, M. A. Ajeel, A. A. H. Al-Bayti. Impact of gamma-aminobutyric acid receptors modulators on renal and liver functional, molecular and histological characteristics in white male mice. Reports of Morphology 2024; 30(4): 82 doi: 10.31393/morphology-journal-2024-30(4)-10
|
| 3 |
Mohammad Amin Elahi Najafi, Masato Yasui, Yuki Teramoto, Tomoyuki Tatenuma, Guiyang Jiang, Hiroshi Miyamoto. GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer. International Journal of Molecular Sciences 2023; 24(18): 13733 doi: 10.3390/ijms241813733
|
| 4 |
Atipat Singkarin, Charat Kusoltech, Jirayu Sriphaiboon, Chatchai Phoomak, Charupong Saengboonmee. Glucose addiction of cholangiocarcinoma: opportunities for therapeutic development. Hepatoma Research 2025; doi: 10.20517/2394-5079.2024.128
|
| 5 |
Ronnakrit Trakoonsenathong, Waritta Kunprom, Chaiwat Aphivatanasiri, Padcharee Yueangchantuek, Paslada Pimkeeree, Supannika Sorin, Kullanat Khawkhiaw, Ching-Feng Chiu, Seiji Okada, Sopit Wongkham, Charupong Saengboonmee. Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivo. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-64774-2
|
| 6 |
Juan Du, Kaiyi Zhang, Jiakun Miao, Yu Yang, Yuying Tian, Tianwen Wu, Cong Tao, Yanfang Wang, Shulin Yang. Molecular pathological characteristics and mechanisms of the liver in metabolic disease-susceptible transgenic pigs. Life Sciences 2025; 362: 123337 doi: 10.1016/j.lfs.2024.123337
|